Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
47.05
-1.61 (-3.31%)
Mar 6, 2026, 11:17 AM EST - Market open
Twist Bioscience Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Revenue | 391.56 | 376.57 | 312.97 | 245.11 | 203.57 | 132.33 | Upgrade
|
| Revenue Growth (YoY) | 18.59% | 20.32% | 27.69% | 20.41% | 53.83% | 46.87% | Upgrade
|
| Cost of Revenue | 189.42 | 185.57 | 179.63 | 155.38 | 119.33 | 80.62 | Upgrade
|
| Gross Profit | 202.13 | 191 | 133.35 | 89.73 | 84.24 | 51.71 | Upgrade
|
| Selling, General & Admin | 260.54 | 246.98 | 218.4 | 189.74 | 212.95 | 135.9 | Upgrade
|
| Research & Development | 76.11 | 80.29 | 90.85 | 106.89 | 120.31 | 69.07 | Upgrade
|
| Operating Expenses | 336.65 | 327.26 | 309.25 | 296.63 | 333.26 | 204.97 | Upgrade
|
| Operating Income | -134.52 | -136.26 | -175.9 | -206.9 | -249.02 | -153.26 | Upgrade
|
| Interest Expense | - | - | - | - | -0.08 | -0.37 | Upgrade
|
| Interest & Investment Income | 10.3 | 11.36 | 15.34 | 14.37 | 3.06 | 0.44 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.34 | -0.9 | -2.68 | -0.67 | -1.09 | - | Upgrade
|
| EBT Excluding Unusual Items | -124.56 | -125.8 | -163.24 | -193.21 | -247.13 | -153.19 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -9.38 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 48.85 | 48.85 | - | - | 4.61 | - | Upgrade
|
| Asset Writedown | - | - | -44.93 | -6.79 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 5.91 | 14.25 | -0.84 | Upgrade
|
| Pretax Income | -75.71 | -76.95 | -208.17 | -203.47 | -228.27 | -154.03 | Upgrade
|
| Income Tax Expense | 0.88 | 0.72 | 0.56 | 1.15 | -10.41 | -1.93 | Upgrade
|
| Net Income | -76.58 | -77.67 | -208.73 | -204.62 | -217.86 | -152.1 | Upgrade
|
| Net Income to Common | -76.58 | -77.67 | -208.73 | -204.62 | -217.86 | -152.1 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 60 | 58 | 57 | 54 | 48 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 60 | 58 | 57 | 54 | 48 | Upgrade
|
| Shares Change (YoY) | 3.17% | 3.09% | 1.99% | 5.57% | 11.68% | 23.12% | Upgrade
|
| EPS (Basic) | -1.27 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | Upgrade
|
| EPS (Diluted) | -1.27 | -1.30 | -3.60 | -3.60 | -4.04 | -3.15 | Upgrade
|
| Free Cash Flow | -86.72 | -75.63 | -69.17 | -170.25 | -226.24 | -139.31 | Upgrade
|
| Free Cash Flow Per Share | -1.44 | -1.26 | -1.19 | -2.99 | -4.20 | -2.89 | Upgrade
|
| Gross Margin | 51.62% | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% | Upgrade
|
| Operating Margin | -34.35% | -36.18% | -56.20% | -84.41% | -122.33% | -115.81% | Upgrade
|
| Profit Margin | -19.56% | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% | Upgrade
|
| Free Cash Flow Margin | -22.15% | -20.08% | -22.10% | -69.46% | -111.14% | -105.27% | Upgrade
|
| EBITDA | -112.75 | -114.31 | -147.07 | -177.59 | -232.51 | -143.51 | Upgrade
|
| EBITDA Margin | -28.79% | -30.35% | -46.99% | -72.45% | -114.22% | -108.45% | Upgrade
|
| D&A For EBITDA | 21.77 | 21.95 | 28.83 | 29.31 | 16.51 | 9.75 | Upgrade
|
| EBIT | -134.52 | -136.26 | -175.9 | -206.9 | -249.02 | -153.26 | Upgrade
|
| EBIT Margin | -34.35% | -36.18% | -56.20% | -84.41% | -122.33% | -115.81% | Upgrade
|
| Advertising Expenses | - | 7 | 5.2 | 2.9 | 2.4 | 2.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.